Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jan, 2017 | Pages:
70 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global medical marijuana market is expected to reach a value of USD 55.8 billion by 2025, according to a new report by Grand View Research, Inc. It has been identified that, in 2016, Washington D.C. along with 28 states have legalized marijuana for medical uses. In 2016, states such as Arkansas, Florida, North Dakota, Ohio, and Pennsylvania were approved to use the drug in medical applications such as chemotherapies and pain management. The growing number of states and countries getting approval for using it in therapeutic applications is one of the crucial factors driving the demand over the coming few years. The presence of several regulatory frameworks such as the Medical Marijuana Regulation and Safety Act is indicators of the present demand for the drug in the market. The regulatory framework requires every individual or the company associated such as growers, retail operators, and makers of processed pot products to obtain permission and an annual state license from 2018. An increasing number of issued licenses is also among factors that is expected to drive the market especially after 2018. The increasing interest amongst the academic researchers and healthcare providers regarding the therapeutic uses of marijuana is among the significant factors, which is driving the market over the coming years. Some of its potential therapeutic values are suppression of vomiting & nausea, pain relief, and appetite stimulation. In addition, research states that marijuana is effective in providing relief to the patient suffering from HIV/AIDS, glaucoma, cancer, and multiple sclerosis. The growing number of therapeutic applications of the drug is one of the key factors that is propelling the market over the forecast period. Further Key Findings From the Study Suggest: In 2015, chronic pain was the largest application segment owing to the presence of a huge patient base The growing prevalence of chronic pain elevates the demand for the drug, thus expected to boost the medical marijuana for chronic pain management The rapidly growing number of cannabis legalization in the U.S. is one of the key attributes for its increased demand in therapeutic and recreational uses, and thus anticipated to impel the market growth Increasing investment in R&D & demand for cannabis in chemotherapy is expected to drive the growth in the Asia Pacific market Some of the key players are Cara Therapeutics Inc.; CannaGrow Holdings, Inc.; Cannabis Sativa, Inc.; United Cannabis Corporation; GrowBlox Sciences, Inc.; GW Pharmaceuticals, plc; Lexaria Corp; International Consolidated Companies, Inc.
Table of Contents
Chapter 1 Research Methodology
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Medical Marijuana Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.2 Market restraint analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Medical Marijuana- SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.4 Industry Analysis - Porter's
Chapter 4 Medical Marijuana Application Estimates & Trend Analysis
4.1 Medical Marijuana Market: Application Movement Analysis
4.2 Chronic Pain
4.2.1 Chronic pain market estimates and forecasts, 2013 - 2025 (USD Million)
4.3 Arthritis
4.3.1 Arthritis market estimates and forecasts, 2013 - 2025 (USD Million)
4.4 Migraine
4.4.1 Migraine market estimates and forecasts, 2013 - 2025 (USD Million)
4.5 Cancer
4.5.1 Cancer market estimates and forecasts, 2013 - 2025 (USD Million)
4.6 Other
4.6.1 Other market estimates and forecasts, 2013 - 2025 (USD Million)
Chapter 5 Medical Marijuana Regional Estimates & Trend Analysis, by Application
5.1 Medical Marijuana Market Share by Region, 2013 & 2025
5.2 North America
5.2.1 North America medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3 Europe
5.3.1 Europe medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.2 Belgium
5.3.2.1 Belgium medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.3 Croatia
5.3.3.1 Croatia medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.4 Finland
5.3.4.1 Finland medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.5 France
5.3.5.1 France medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.6 Italy
5.3.6.1 Italy medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.7 Netherlands
5.3.7.1 Netherlands medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.8 Portugal
5.3.8.1 Portugal medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.9 Romania
5.3.9.1 Romania medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.10 Switzerland
5.3.10.1 Switzerland medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.11 Czech Republic
5.3.11.1 Czech Republic medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.3.12 Estonia
5.3.12.1 Estonia medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.4 ROW
5.4.1 ROW medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
5.4.2 Israel
5.4.2.1 Israel medical marijuana market estimates and forecasts, 2013 - 2025 (USD Million)
Chapter 6 Competitive Landscape
6.1 Cara Therapeutics Inc.
6.1.1 Company overview
6.1.2 Financial performance
6.1.3 Product benchmarking
6.1.4 Strategic initiatives
6.2 Cannabis Sativa, Inc.
6.2.1 Company overview
6.2.2 Financial performance
6.2.3 Product benchmarking
6.2.4 Strategic initiatives
6.3 CannaGrow Holdings, Inc.
6.3.1 Company overview
6.3.2 Financial performance
6.3.3 Product benchmarking
6.3.4 Strategic initiatives
6.4 United Cannabis Corporation
6.4.1 Company overview
6.4.2 Financial performance
6.4.3 Product benchmarking
6.4.4 Strategic initiatives
6.5 United Cannabis Corporation
6.5.1 Company overview
6.5.2 Financial performance
6.5.3 Product benchmarking
6.5.4 Strategic initiatives
6.6 Growblox Sciences, Inc.
6.6.1 Company overview
6.6.2 Financial performance
6.6.3 Product benchmarking
6.6.4 Strategic initiatives
6.7 GreenGro Technologies, Inc.
6.7.1 Company overview
6.7.2 Financial performance
6.7.3 Product benchmarking
6.7.4 Strategic initiatives
6.8 GW Pharmaceuticals plc
6.8.1 Company overview
6.8.2 Financial performance
6.8.3 Product benchmarking
6.8.4 Strategic initiatives
6.9 International Consolidated Companies, Inc.
6.9.1 Company overview
6.9.2 Financial performance
6.9.3 Product benchmarking
6.9.4 Strategic initiatives
6.10 Lexaria Corp.
6.10.1 Company overview
6.10.2 Financial performance
6.10.3 Product benchmarking
6.10.4 Strategic initiatives
List of Tables TABLE 1 North America medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 2 U.S. medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 3 Canada medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 4 Europe medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 5 Belgium medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 6 Croatia medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 7 Finland medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 8 France medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 9 Italy medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 10 Netherlands medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 11 Portugal medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 12 Romania medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 13 Switzerland medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 14 Czech Republic medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 15 Estonia medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 16 ROW medical marijuana market, by application, 2013 - 2025 (USD Million) TABLE 17 Israel medical marijuana market, by application, 2013 - 2025 (USD Million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
